跳至主要内容
临床试验/JPRN-UMIN000020199
JPRN-UMIN000020199已完成2 期

Hypofractionated proton beam therapy for localized prostate cancer - Hypofractionated proton beam therapy for localized prostate cancer

Aizawa hospital0 个研究点目标入组 120 人开始时间: 2015年12月15日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) With active other cancers 2) With severe uncontrolled diabetes 3) With severe heart disease, or some serious complications, i.e., SLE, Scleroderma, interstitial pneumonia 4) Allergic to radiation 5) Previous surgical treatment for prostate disease before enrollment 6) Previous chemotherapy (except holmonal therapy)for prostate cancer before enrollment 7) Previous radiotherapy to pelvis 8) With implantable cardioverter defibrillator or permanent pacemaker 9) Considered that participation in this trial is difficult because of psychiatric symptoms or psychosis 10) Cannot be held rest for about 60 minutes 11) Cannot be implanted Au marker in the prostate 12) Unsuitable for enrollment judged by principal investigator

研究者

相似试验